Hypofractionated whole breast radiation and partial breast radiation for early-stage breast cancers: An update on progress

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 10, Issue 9, 2012, Pages 1161-1164

  McCormick, Beryl ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; TAXANE DERIVATIVE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL (TOPIC); HUMAN; INTRADUCTAL CARCINOMA; PARTIAL BREAST IRRADIATION; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL (TOPIC); PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; WHOLE BREAST RADIOTHERAPY;

EID: 84866553675     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2012.0119     Document Type: Short Survey

References (13)

1. McCormick B. Partial-breast radiation for early staged breast cancers: hypothesis, existing data and a planned phase III trial. J Natl Compr Canc Netw 2005;3:301-307.
2. White J. Update on breast cancer open protocols, RTOG Breast Committee. RTOG Semiannual Meeting; June 14-17, 2012; Philadelphia, PA.
3. Orecchia R. Results of the Milan PBI ELIOT Trial. World Congress of Brachytherapy; May 10-12, 2012; Barcelona, Spain.
4. Vaidya J, Joseph D, Tobias J, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT A Trial): an international, prospective, randomized, non-inferiority phase 3 trial. Lancet 2010;376:91-102. Erratum in: Lancet 2010;376:90.
5. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Am Coll Surg 2009;209:269-277.
6. Recht A, Ancukiewicz M, Alm El-Din MA, et al. Lung dose - volume parameters and the risk of pneumonitis for patients treated with accelerated partial-breast irradiation using three-dimensional conformal radiotherapy. J Clin Oncol 2009;27:3887-3893.
7. Hepel T, Tokita M, MacAusland SG, et al. Toxicity of three- dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2009;75:1290-1296.
8. Jagsi R, Ben-David MA, Moran JM, et al. Unacceptable cosmesis in a protocol investigating intensity- modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2010;76:71-78.
9. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomized trial. Radiother Oncol 2005;75:9-17.
10. Bentzen SM, Agrawal RK, Aird EG, et al. START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9:331-341.
11. The START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial. Lancet 2008;371:1098-1107.
12. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-520.
13. Croog VJ, Wu AJ, McCormick E, Beal KP. Accelerated whole breast irradiation with intensity modulated radiotherapy to the prone breast. lnt J Radiat Oncol Biol Phys 2009;73:88-93.